Share. Connect. Create. Grow. · Socialiya
Q32’s stock jumps 60% on latest phase 2 alopecia data for potential rival to JAK inhibitors

The latest phase 2 readout for Q32 Bio's alopecia hopeful received a warm reception from investors,...

BUSINESS NEWS July 13, 2026

Q32’s stock jumps 60% on latest phase 2 alopecia data for potential rival to JAK inhibitors

The latest phase 2 readout for Q32 Bio's alopecia hopeful received a warm reception from investors, backing up the biotech's claim that the drug could offer...

6 views 0 likes 0 comments
Share:
The latest phase 2 readout for Q32 Bio's alopecia hopeful received a warm reception from investors, backing up the biotech's claim that the drug could offer...

Author: Fierce Biotech

Read Original Article

Related News

Advertisement
socialiya
Advertisement

Top Categories

Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya